Publication
Regulatory investigations and enforcement: Key developments
The past six months have seen a number of key changes in the regulatory investigations and enforcement space.
Mitigating tariff risks for healthcare in US and Canada
Law 360
The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]
Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
Recent publications
Publication
Low carbon projects: Global hydrogen and CCS market insights
Low carbon projects, especially those involving hydrogen and carbon capture and storage (CCS), play a crucial role in the journey towards global decarbonization.
Publication
The landscape of insurance claims
The insurance industry is facing a rapidly changing litigation environment. Emerging risks, regulatory developments, and technological advancements are reshaping how insurers approach underwriting, claims, and risk management. Below is an overview of the most significant trends impacting the sector.
Subscribe and stay up to date with the latest legal news, information and events . . .